Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fu

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Lakartidningen|July 20, 2016
[Sacubitril-valsartan is a new cornerstone in heart failure therapy]Lars H Lund, Michael Fu, Karl Swedberg
ESC Heart Failure|February 8, 2020
Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical settingCharlotte Nordberg Backelin, Michael Fu, Charlotta Ljungman
ESC Heart Failure|October 7, 2023
Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrumXiaojing Chen, Yu Kang, Ulf Dahlström, et al.
International Journal of Cardiology|March 27, 2017
Answer to Dr. EyubogluSilvana Kontogeorgos, Erik Thunström, Magnus Johansson, et al.
European Journal of Pharmacology|July 17, 2012
Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunctionBiqi Zhang, Lihong Qiu, Michael Fu, et al.
BMC Gastroenterology|April 9, 2014
Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosisAxel Josefsson, Michael Fu, Einar Björnsson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 26, 2024
Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020Patric Karlström, Aldina Pivodic, Ulf Dahlström, et al.
ESC Heart Failure|November 27, 2023
Sodium-glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failurePatric Karlström, Aldina Pivodic, Ulf Dahlström, et al.
Patient Preference and Adherence|August 15, 2023
Experiences of Heart Failure and the Treatment Journey: A Mixed-Methods Study Among Patients with Heart Failure in SwedenMaria Liljeroos, Björn Agvall, Daniel Eek, et al.
International Journal of Cardiology|February 1, 2008
Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort studyEspen Haugen, Yutaka Furukawa, Azra Isic, et al.
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Lakartidningen|July 20, 2016
[Sacubitril-valsartan is a new cornerstone in heart failure therapy]Lars H Lund, Michael Fu, Karl Swedberg
ESC Heart Failure|February 8, 2020
Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical settingCharlotte Nordberg Backelin, Michael Fu, Charlotta Ljungman
ESC Heart Failure|October 7, 2023
Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrumXiaojing Chen, Yu Kang, Ulf Dahlström, et al.
International Journal of Cardiology|March 27, 2017
Answer to Dr. EyubogluSilvana Kontogeorgos, Erik Thunström, Magnus Johansson, et al.
European Journal of Pharmacology|July 17, 2012
Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunctionBiqi Zhang, Lihong Qiu, Michael Fu, et al.
BMC Gastroenterology|April 9, 2014
Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosisAxel Josefsson, Michael Fu, Einar Björnsson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 26, 2024
Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020Patric Karlström, Aldina Pivodic, Ulf Dahlström, et al.
ESC Heart Failure|November 27, 2023
Sodium-glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failurePatric Karlström, Aldina Pivodic, Ulf Dahlström, et al.
Patient Preference and Adherence|August 15, 2023
Experiences of Heart Failure and the Treatment Journey: A Mixed-Methods Study Among Patients with Heart Failure in SwedenMaria Liljeroos, Björn Agvall, Daniel Eek, et al.
International Journal of Cardiology|February 1, 2008
Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort studyEspen Haugen, Yutaka Furukawa, Azra Isic, et al.
Pageof 21